Use of convalescent plasma in COVID‐19 patients with immunosuppression

In the absence of effective countermeasures, human convalescent plasma has been widely used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel coronavirus disease 19 (COVID‐19), including among patients with innate or acquired immunosuppression. However, the assoc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transfusion
Main Authors: Senefeld, Jonathon W., Klassen, Stephen A., Ford, Shane K., Senese, Katherine A., Wiggins, Chad C., Bostrom, Bruce C., Thompson, Michael A., Baker, Sarah E., Nicholson, Wayne T., Johnson, Patrick W., Carter, Rickey E., Henderson, Jeffrey P., Hartman, William R., Pirofski, Liise‐anne, Wright, R. Scott, Fairweather, De Lisa, Bruno, Katelyn A., Paneth, Nigel S., Casadevall, Arturo, Joyner, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2021
Assuntos:
Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8242637/
https://ncbi.nlm.nih.gov/pubmed/34036587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.16525
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados